Contact this trialFirst, we need to learn more about you.
HC-7366 for Advanced Solid Cancers
Recruiting1 awardPhase 1
Nashville, Tennessee
This trial is testing a new cancer drug to see what the maximum tolerated dose is, what the recommended Phase 2 dose is, and to evaluate its safety and how well it is tolerated when taken orally once a day. The trial will enroll 36 subjects with advanced solid tumors, with up to 15 additional subjects in the expansion phase. The study will be conducted in the United States at 3-5 sites.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.